Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Stendra avanafil: Phase IV data

The double-blind, U.S. Phase IV TA-501 trial in 440 men with mild to severe ED showed that Stendra administered about 15 minutes prior to attempting

Read the full 251 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE